APA (7th ed.) Citation

K, P., O, R., E, S., M, W., J, Z., & SC, C. (2026). The long-term cardiovascular safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in high-risk cardiovascular populations: A systematic review and meta-analysis. Cardiovascular diabetology. Endocrinology reports, 12(1), . https://doi.org/10.1186/s40842-026-00295-3

Chicago Style (17th ed.) Citation

K, Peter, Roka O, Sepp E, Warburton M, Zhang J, and Cork SC. "The Long-term Cardiovascular Safety and Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists in High-risk Cardiovascular Populations: A Systematic Review and Meta-analysis." Cardiovascular Diabetology. Endocrinology Reports 12, no. 1 (2026). https://doi.org/10.1186/s40842-026-00295-3.

MLA (9th ed.) Citation

K, Peter, et al. "The Long-term Cardiovascular Safety and Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists in High-risk Cardiovascular Populations: A Systematic Review and Meta-analysis." Cardiovascular Diabetology. Endocrinology Reports, vol. 12, no. 1, 2026, https://doi.org/10.1186/s40842-026-00295-3.